Peptone Market Outlook from 2024 to 2034

The global sale of peptone is estimated to be worth USD 846.4 million in 2024 and is anticipated to reach a value of USD 1,299.0 million by 2034. Sales are projected to rise at a CAGR of 4.4% over the forecast period between 2024 and 2034. The revenue generated by peptone in 2023 was USD 818.5 million.

The industry is predicted to exhibit a Y-o-Y growth of 3.4% in 2024. This projected growth indicates a value growth of nearly 1.5X from the current value over the study period

The peptone water is widely used as diluent and nutrient enrichment broth for the resuscitation and growth of a wide variety of microorganisms, including Cronobacter, Enterobacteriaceae, Escherichia coli and Salmonella, in all food and feed products and water samples.

Peptone in the form of water/liquid is suitable for demanding strains, rigorous growth conditions and difficult protocols making it ideal product to be used in microbiology application.

Peptone has the ability to be modified based on the application. For instance, peptone can be modified into peptone water and can be used in carbohydrate fermentation assays. All these factors are driving the demand for peptone.

Secondary metabolism and antimicrobial metabolites of aspergillus further drives the growth of the peptone market. Peptones are widely used in the production of antimicrobial metabolites of Aspergillus. Aspergillus are starch-degrading enzymes and are considered as an important enzyme in the industrial applications.

Amylase a type of starch-degrading enzyme has high biotechnological relevance making it ideal to be used across textiles, beer, liquor, bakery, infant feeding cereals, starch liquefaction-saccharification, and animal feed industries. The growing demand for metabolites will directly impact on the growth of peptone market.

Attributes Key Insights
Estimated Value (2024) USD 846.4 million
Projected Size (2034) USD 1,299.0 million
Value-based CAGR (2024 to 2034) 4.4%

Peptone Powder remains dominant in the form segment. Peptone powder are used to produce microbiological culture media, industrial fermentations and media fill trials. Growth mediums used in the industrial microbiology industry needs natural sources of amino acids, carbohydrates, vitamins and proteins for proper growth of the media.

Peptone in form of powder is considered as the viable source capable of producing natural source of amino acids, vitamins, carbohydrates, and proteins. Other applications of peptone powder includes stabilizer in clinical formulations and amylase in food industry. The food industry uses amylase for diverse applications including conversion of starch into dextrin, conversion of starch into maltose, conversion of glucose into fructose, and others.

Amylase are proven to improve bread color, volume, and texture in the baking industry. In addition, the use of amylase in bakery products tend to retards its aging process and maintains fresh bread for a longer duration.

Different types of amylase such as fungal amylase and amyloglucosidase are widely used in the bakery products as these tend to offer high fermentation potential, enhance flavor, taste, and provide better bread crust softness. All these factors are impacting positively on the growth of the peptone powder.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Industry Highlights

The growing demand for secondary and antimicrobial metabolites of Aspergillus in textile, bakery, and beverage industry.

Starch-degrading enzymes are type of amylase that are industrially produced since 20th century owing to their wide industrial applications. The starch-degrading enzymes accounts nearly for 25% share of the total enzymes market marking it as a remarkable industrial enzyme.

The production of starch-degrading enzyme requires peptone in form of powder as the powdered peptone is considered to be viable as compared to other additives commercially available in the market. Biotechnological relevance is another prime factor that makes amylase an important industrial enzyme in applications such as beer, liquor, bakery products, starch liquefaction-saccharification, and others.

Food industry heavily relies on starch to dextrin conversion. This conversion is further employed in the production of stabilizers and thickeners in the food industry. Furthermore, confectionery and beverage industry (alcoholic and non-alcoholic) relies heavily on starch to maltose conversion.

This conversion aids the production process of soft drinks, beer, jellies and ice cream. All these factors are driving the demand for industrial enzymes that in turn drives the production and demand for peptones.

Peptone water as a non-selective liquid media for microbiology.

Peptone water is a non-selective broth media that is used as a primary enrichment medium for bacterial growth in the microbiology industry. Peptone powder are used to produce microbiological culture media, industrial fermentations and media fill trials. Non-selective media uses different broths such as brain heart broth, LB broth, nutrient broth, TAT broth, yeast malt broth, and others.

However, several research paper have demonstrated the efficiency of peptone water over other media’s. Key ingredients of culture media include peptone, beef extract, yeast extract, distilled water, and agar. The adoption of culture media depends upon the intended application.

For instance, the development/production of microbes uses yeast extract wherein the production of isolate pure culture media uses peptone. However, mostly the peptone is used as culture media owing to its efficiency and product characteristics.

The applications of culture media in microbiology includes microbe cultivation & production, identification of infection cause, identification of microorganism characteristics, isolation of culture media, production of antigens for laboratory use, and several others.

All these applications require culture media to increase the efficiency of the process. Thus, the demand for peptone as non-selective liquid media in microbiology drives the growth of the global market.

Innovation in vaccine, antibiotic, and steroid production.

Peptones are used in the commercial production of enzymes, vaccines, antibiotics, steroids, and other products. Vaccine production is considered as the demanding application that requires a proper portfolio of culture media and other additives such as serums. Several research & development are carried out to address the current challenges of vaccine development.

For instance, nucleic acid vaccines, mRNA vaccines, vector vaccines, and biomaterial-based vaccines are recent trends in the revolutionization of vaccines. Key players in the peptone market offer tailored specific products that are used as alternatives over serum in vaccine development.

Thermo Fisher a leading provider of biotechnology products offers extensive portfolio of animal origin-free peptone that are used in the development and production of advanced vaccines. Peptones are considered as alternative over serum in the vaccine production owing to the source of origin, efficiency, and cost. Peptones are proven to increase the production process and performance of the vaccines.

Combined with the constant development in vaccine production & technology along with growing demand for advanced vaccines for treating life threatening diseases is foreseen to drive the adoption of peptones in the near future.

Peptones are considered as an established supplements for vaccine development and production. Vaccine developers mainly concentrate on increasing productivity combined with reducing the per-unit cost of the vaccines. Cell culture media, feeds, and alternative to serums plays crucial role in driving down the cost of vaccines and efficiency.

Peptone are rich in carbohydrates, nucleosides, peptides, vitamins, amino acids, and minerals making them an ideal and viable source in the vaccine industry. This adaptable, reasonably priced product can also be used in place of serum, improving results and providing cellular protection. Peptones have been crucial to the development of viral vaccines for many years, and they help bring the vaccine to market more quickly and affordably.

Yeast peptone emerges as the future of peptones, offering sustainable, efficient, and versatile applications across diverse industries.

Yeast peptone is increasingly being used as an alternative constituent of complex culture media. Like yeast extract and peptone of animal or vegetable origin, other frequently used ingredients of complex media such as YM agar and broth, the chemical composition of yeast peptone is not precisely defined.

However, with regard to general composition and properties it differs from traditional culture media ingredients, offering several advantages to make it the ideal choice for numerous applications in industry and the microbiology lab. Yeast peptone is typically made available as a powder or in a micro-agglomerated format.

Yeast peptone are derived from specific strains, thus, these peptones are less variable in composition as compared to plant and animal derived protein sources, so performance consistency is better. In fact, it is possible to produce yeast peptones with specific properties, for example a certain total nitrogen and amino nitrogen content, pH range, molecular weight distribution of peptides or growth promotion ability.

The choice of yeast peptone can thus be used to influence parameters such as microbial growth, biomass, metabolite production, acidity, cell viability or cell resistance in the downstream process. Growth promotion tends to be much better than when using casein peptone.

Acid hydrolysates of casein to replace peptone in the preparation of bacteriological media and biosafety risks of animal-origin peptones

Peptones are predominantly used as culture media for the growth of pathogenic bacteria. However, there are several disadvantages associated with use of peptone such as peptone presence interferes with the isolation in pure form of the various products of bacterial growth, toxins, specific carbohydrates, and others.

This factor has demanded for the use of casein hydrolysates as culture media over peptone. An additional drawback lies in the variation between lots of peptone, even of the same brand, which is inevitable and due to the methods of production.

The need to minimize animal-derived components in the production process has created an interest in using protein hydrolysates (peptones) as alternative supplements to replace serum. Peptones are water-soluble, protein hydrolysates of non-chemically-defined nature, containing peptides, amino acids, and inorganic salts, but devoid of lipids and sugars.

This category of media components are low-cost, growth-promoting nutrients for intensive animal cell culture that supply nutrients or growth factor analogues based on degree of hydrolysis. Various peptones are commercially available such as digest of beef tissues, meat, casein, lactalbumin, and yeast. The main disadvantage of most of these peptones is their animal origin which endangers medium biosafety.

2019 to 2023 Global Peptone Sales Outlook Compared to Demand Forecast from 2024 to 2034

The peptone recorded a CAGR of 2.5% during the historical period between 2019 and 2023. The growth of peptone was positive as it reached a value of USD 818.5 million in 2023 from USD 740.6 million in 2019.

Between 2019 and 2023, the global peptone market experienced a notable shift, largely influenced by the COVID-19 pandemic and its broader effects on the microbiology industry. COVID-19 pandemic had negative influence on the growth of the peptone market. Factors such as disrupted supply chain, raw material availability, and minimal production/industrial activity affected the peptone market significantly in the pandemic.

The demand for microbiology media declined in the pandemic owing to minimal scaling of industrial and research laboratories. However, the demand for vaccines and biopharmaceutical development gained traction that in turn surged the sales of peptones.

The peptone market witnessed positive growth in 2021 as compared to 2020. Regions such as North America, Europe, and Asia-Pacific were forefront in the development of novel vaccines thereby increasing the demand for peptone across these regions.

From 2024 to 2034, the demand for peptone is expected to rise steadily owing to rise in adoption of peptone water as diluent & nutrient enrichment broth, adoption of peptone in treatment of nutritional deficiencies, and rising importance of peptone in food & beverage industry.

The production of starch-degrading enzyme requires peptone in form of powder as the powdered peptone is considered to be viable as compared to other additives commercially available in the market. Biotechnological relevance is another prime factor that makes amylase an important industrial enzyme in applications such as beer, liquor, bakery products, starch liquefaction-saccharification, and others.

Food industry heavily relies on starch to dextrin conversion. This conversion is further employed in the production of stabilizers and thickeners in the food industry. Furthermore, confectionery and beverage industry (alcoholic and non-alcoholic) relies heavily on starch to maltose conversion. This conversion aids the production process of soft drinks, beer, jellies and ice cream. All these factors are driving the demand for industrial enzymes that in turn drives the production and demand for peptones.

Nikhil Kaitwade
Nikhil Kaitwade

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Market Concentration

Tier 1 companies comprise players with a revenue of above USD 200 million capturing a significant share of 35-40% in the global market. These players are characterized by high production capacity and a wide product portfolio.

These leaders are distinguished by their extensive expertise in manufacturing and reconditioning across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base. Prominent companies within Tier 1 include Merck KGaA, VWR International, LLC, Neogen Corporation, Carl Roth GmbH & Co. KG, Solabia Group and other players.

Tier 2 companies include mid-size players with revenue of below USD 200 million having a presence in specific regions and highly influencing the local industry. These are characterized by a strong presence overseas and strong industry knowledge.

These players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include HiMedia Laboratories, Sisco Research Laboratories Pvt. Ltd., Apollo Scientific Ltd, Biolife Italiana S.r.l. and other player.

Country-wise Insights

The section below covers the industry analysis for peptone demand in different countries. The demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia Pacific, Western Europe, Eastern Europe, Middle East, and Africa is provided.

China will hold 61.3% in East Asia due to its robust biopharmaceutical industry and large-scale industrial base. The USA will capture 75.6% in North America owing to federal funding and policies encouraging vaccine development and healthcare innovations. Germany will lead Western Europe with 25.9% due to growing emphasis on sustainable and plant-based peptones aligns with Germany’s commitment to environmentally friendly bioprocesses.

Countries Value CAGR (2024 to 2034)
Brazil 3.9%
India 5.4%
The USA 4.1%
Germany 5.3%
China 5.9%

China's growth is driven by robust biopharmaceutical industry and large-scale industrial base.

The sale of peptone in China is projected to reach USD 104.3 million and is estimated to grow at a 5.9% CAGR by 2034.

China has a significant focus on vaccine production, particularly for infectious diseases and emerging health threats, where peptones are used as essential media components. The country's biopharmaceutical sector is rapidly growing, with an increasing number of companies manufacturing biologics that rely on high-quality peptones for cell culture processes. In addition, government initiatives, such as "Made in China 2025," prioritize biopharmaceutical advancements, fostering demand for key inputs like peptones.

USA growth is fueled by robust research & development ecosystem and expanding food & beverage industry.

The sales in the USA are projected to reach USD 298.5 million by 2034. Over the forecast period, demand for peptone industry within the USA is predicted to grow at a 4.1% CAGR.

The USA invests heavily in biotechnology and life sciences research, fueling the demand for peptones in microbial culture, cell-based research, and diagnostics. Government initiatives, such as grants from the National Institutes of Health (NIH), bolster innovation in biologics, microbiology, and bioprocessing.

Peptones play a critical role in fermentation processes used in the production of probiotics, alternative proteins, and dairy products like yogurt and cheese. Rising consumer interest in plant-based foods, functional beverages, and probiotics has amplified the need for peptones in food innovation. The USA food industry’s adherence to high safety and quality standards ensures the consistent demand for premium-grade peptones.

Germany's growth is driven by strong industrial base, advanced research ecosystem, and leadership in biotechnological, pharmaceutical, and food industries.

The sale of peptone in Germany is projected to reach USD 27.3 million and grow at a CAGR of 5.3% by 2034.

Germany is home to some of Europe’s largest pharmaceutical and biotechnology companies, including Bayer, Boehringer Ingelheim, and Merck, all of which are major consumers of peptones for cell culture media used in biologics and vaccine production. As the demand for biologics and biosimilars rises across Europe, Germany has been at the forefront of this growth, creating an ongoing need for peptones in the manufacturing of monoclonal antibodies, therapeutic proteins, and other biologics.

Germany’s robust life sciences research ecosystem, supported by its world-class universities and research institutions (e.g., Max Planck Institute, Fraunhofer Society), drives innovation in biotechnology and the use of peptones in research and development. Research and development in synthetic biology, cell-based therapies, and personalized medicine continue to fuel demand for specialized peptones, making Germany a global leader in these fields.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

The section explains the growth trajectories of the leading segments in the industry. In terms of form type, the peptone powder type will likely dominate and generate a share of around 74.9% in 2024.

Based on the application, the microbiology segment is projected to hold a major share of 45.0% in 2024. The analysis would enable potential clients to make effective business decisions for investment purposes.

Widespread application of powder peptone in biotechnology drives the growth of powder

Segment Peptone Powder (Form)
Value Share (2024) 74.9%

The growth of the powder peptone segment is fueled by its functional advantages, expanding applications in biotechnology and food industries, and the increasing demand for high-quality, sustainable solutions. Continuous advancements in production technologies, combined with rising adoption in emerging and established markets, ensure robust growth for this segment in the coming years.

Powder peptones are highly soluble and stable, making them ideal for large-scale industrial applications. They are easy to measure, store, and mix into culture media, reducing handling complexities compared to liquid alternatives. Powdered forms ensure uniformity in concentration and quality, which is critical for reproducible results in scientific and industrial processes. This reliability fuels demand in pharmaceutical and biotechnology sectors.

Microbiology application drive growth in peptone market.

Segment Microbiology (Application)
Value Share (2024) 45.0%

The rising prevalence of infectious diseases and antimicrobial resistance has led to an increased need for effective diagnostic systems. Peptone-enriched culture media are pivotal for isolating and identifying bacterial and fungal pathogens in clinical samples, ensuring timely and accurate treatment decisions.

Advanced molecular biology tools, such as next-generation sequencing (NGS), require cultured microbial strains for genetic studies. Peptones ensure optimal growth conditions, enabling researchers to analyze microbial communities and develop solutions for challenges in healthcare, agriculture, and environmental science.

Competitive Landscape

Key companies manufacturing peptone slightly consolidate the market with about 40-45% share that are prioritizing technological advancements, integrating sustainable practices, and expanding their footprints in the region.

Customer satisfaction remains paramount, with a keen focus on tailoring peptone to meet diverse industry needs. These industry leaders’ actively foster collaborations to stay at the forefront of innovation, ensuring their peptone align with the evolving demands and maintain the highest standards of quality and adaptability.

Recent Industry Developments

  • In March 2023, Thermo Fisher Scientific launched the Gibco, product line with new animal-free peptone formulations for biopharmaceutical applications. This development aimed to address the growing demand for non-animal-based components in cell culture media, driven by regulatory requirements and the need for ethical sourcing. The launch bolstered Thermo Fisher’s position in the bioprocessing market.
  • In September 2022, Kerry Group launched plant-derived peptones for use in microbiological media and industrial fermentation. By leveraging its expertise in plant-based nutrition, Kerry Group catered to the increasing preference for sustainable and vegan-friendly peptones in pharmaceutical and food microbiology.

Key Players

  • Merck KGaA
  • VWR International, LLC
  • HiMedia Laboratories
  • Sisco Research Laboratories Pvt. Ltd.
  • Titan Biotech Limited
  • CONDALAB
  • Clinisciences Group
  • Neogen Corporation
  • AngelYeast Co., Ltd.
  • Tulip Diagnostics Pvt. Ltd.
  • Apollo Scientific Ltd
  • Amyl Media Pty Ltd
  • Carl Roth GmbH & Co. KG
  • Biolife Italiana S.r.l.
  • Southern Biological
  • Central Drug House
  • Duchefa Biochemie
  • Loba Chemie Pvt. Ltd.
  • Solabia Group

Key Segmentation

By Form Type:

The Form Type segment is further categorized into Peptone Powder and Peptone Water.

By Application:

The Application segment is classified into Microbiology, Food & Beverages, Academic & Research, and Others.

By Region:

Regions considered in the study include North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and the Middle East and Africa.

Frequently Asked Questions

What was the overall size of the peptone in multiple applications in 2023?

The peptone used in microbiology were valued at USD 369.9 million in 2023.

How big is the peptone market expected in 2024?

The demand for peptone is set to reach USD 1,299.0 million in 2024.

What will drive the demand for peptone during the forecast period?

The global probiotics market is expanding due to growing awareness of gut health. Peptone-based media enable the cultivation of beneficial bacteria such as Lactobacillus and Bifidobacterium, which are central to probiotic formulations to drive the demand for peptone during the forecast period.

What is the projected demand for peptone during the forecast period?

The peptone demand is projected to reach USD 1,299.0 million by 2034.

Which segment in form type is expected to lead in peptone manufacturing?

Peptone powder segment is expected to lead during the forecast period.

Table of Content
  • 1. Executive Summary
  • 2. Industry Introduction, including Taxonomy and Market Definition
  • 3. Market Trends and Success Factors
    • 3.1. Macro-economic Factors
    • 3.2. Market Dynamics
    • 3.3. Recent Industry Developments
  • 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034
    • 4.1. Historical Analysis
    • 4.2. Future Projections
  • 5. Pricing Analysis
  • 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
    • 6.1. Form
    • 6.2. Application
  • 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form
    • 7.1. Powder
      • 7.1.1. Plant
        • 7.1.1.1. Soy
        • 7.1.1.2. Corn
        • 7.1.1.3. Wheat
        • 7.1.1.4. Rice
        • 7.1.1.5. Others
      • 7.1.2. Animal
        • 7.1.2.1. Bovine
        • 7.1.2.2. Porcine
        • 7.1.2.3. Casein
        • 7.1.2.4. Gelatin
        • 7.1.2.5. Others
    • 7.2. Water
      • 7.2.1. Plant
        • 7.2.1.1. Soy
        • 7.2.1.2. Corn
        • 7.2.1.3. Wheat
        • 7.2.1.4. Rice
        • 7.2.1.5. Others
      • 7.2.2. Animal
        • 7.2.2.1. Bovine
        • 7.2.2.2. Porcine
        • 7.2.2.3. Casein
        • 7.2.2.4. Gelatin
        • 7.2.2.5. Others
  • 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
    • 8.1. Microbiology
      • 8.1.1. Culture Media Preparation
      • 8.1.2. Pathogen Testing
      • 8.1.3. Environmental Monitoring
    • 8.2. Food & Beverages
      • 8.2.1. Dairy
      • 8.2.2. Meat
      • 8.2.3. Bakery
      • 8.2.4. Beverage Processing
    • 8.3. Academic & Research
      • 8.3.1. Biopharmaceuticals
      • 8.3.2. Vaccine Development
      • 8.3.3. Cell Culture Media
      • 8.3.4. Diagnostics
      • 8.3.5. Others
    • 8.4. Others
  • 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    • 9.1. North America
    • 9.2. Latin America
    • 9.3. Western Europe
    • 9.4. South Asia
    • 9.5. East Asia
    • 9.6. Eastern Europe
    • 9.7. Middle East & Africa
  • 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 13. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
  • 17. Sales Forecast 2024 to 2034 by Form and Application for 30 Countries
  • 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
  • 19. Company Profile
    • 19.1. Merck KGaA
    • 19.2. VWR International, LLC
    • 19.3. HiMedia Laboratories
    • 19.4. Sisco Research Laboratories Pvt. Ltd.
    • 19.5. Titan Biotech Limited
    • 19.6. CONDALAB
    • 19.7. Clinisciences Group
    • 19.8. Neogen Corporation
    • 19.9. AngelYeast Co., Ltd.
    • 19.10. Tulip Diagnostics Pvt. Ltd.
    • 19.11. Apollo Scientific Ltd
    • 19.12. Amyl Media Pty Ltd
    • 19.13. Carl Roth GmbH & Co. KG
    • 19.14. Biolife Italiana S.r.l.
    • 19.15. Southern Biological
    • 19.16. Central Drug House
    • 19.17. Duchefa Biochemie
    • 19.18. Loba Chemie Pvt. Ltd.
    • 19.19. Solabia Group
    • 19.20. Other Key Players

Explore Chemicals & Materials Insights

View Reports
Future Market Insights

Peptone Market

Schedule a Call